Interferon alpha therapy in HBeAg-negative chronic hepatitis B: new data in support of long-term efficacy
- 1 February 2002
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 36 (2) , 280-282
- https://doi.org/10.1016/s0168-8278(01)00314-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Hepatitis B e antigen-negative chronic hepatitis BHepatology, 2001
- The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis BJournal of Hepatology, 2001
- Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis BHepatology, 2000
- Hepatitis B e antigen-negative chronic hepatitis b in Hong KongHepatology, 2000
- A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serumHepatology, 1997
- A Randomized Controlled Trial of Lymphoblastoid Interferon–α in Patients With Chronic Hepatitis B Lacking HbeagHepatology, 1992
- Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferonJournal of Hepatology, 1992
- Treatment with interferon of chronic hepatitis B associated with antibody to hepatitis B e antigenJournal of Hepatology, 1991
- Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type BJournal of Hepatology, 1990
- Analysis of Liver Disease, Nuclear HBcAg, Viral Replication, and Hepatitis B Virus DNA in Liver and Serum of HBcAg Vs. Anti-HBe Positive Carriers of Hepatitis B VirusHepatology, 1983